Search bioRxivSearch

bioRxiv · 10.1101/585976

Deficient stereopsis in the normal population revisited: why current clinical stereo tests may not be adequate

Abstract

Significance statementApplied applications for occupational screening, clinical tests should assess sensitivity to the sign as well as the magnitude of disparity.\n\nPurposeTo determine why the high incidence of stereo anomaly found using laboratory tests with polarity-based increment judgements (i.e., depth sign) is not reflected in clinical measurements that involve single-polarity incremental judgements (i.e., depth magnitude).\n\nMethodsAn iPod-based measurement that involved the detection of an oriented shape defined by a single polarity-depth increment within a random dot display was used. A staircase procedure was used to gather sufficient trials to derive a meaningful measure of variance for the measurement of stereopsis over a large disparity range. Forty-five adults with normal binocular vision (20 - 65 years old) and normal or corrected-to-normal (0 logMAR or better) monocular vision participated in this study.\n\nResultsObservers stereo acuities ranged between 10 and 100 arc seconds, and were normally distributed on a log scale (p = 0.90, 2-tailed Shapiro-Wilk test). The present results using a single polarity depth increment task (i.e., depth magnitude) show a similar distribution to those using a similar task using the Randot preschool stereo test on individuals between the ages of 19-35 using either the 4-book test (n = 33) or the 3-book test (n = 40), but very different results when the iPod test involved a polarity-based increment judgement (i.e., depth sign).\n\nConclusionsThe present clinical stereo tests are based on magnitude judgements and are unable to detect the high percentage of stereo anomalous individuals in the normal population revealed using depth sign judgements.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Hess, R. F., Dillon, R., Ding, R., Zhou, J.. 2019-03-31. Deficient stereopsis in the normal population revisited: why current clinical stereo tests may not be adequate. https://doi.org/10.1101/585976

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience